17 results
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
Purchaser listed in response to Item 1 above:
The Tax Identification Number (or, if an individual, the Social Security Number) of the Registered Purchaser
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
) owns or possesses valid and adequate rights to use any and all patents and patent applications; trademarks, service marks, domain names, social … person’s name, street address, telephone number, e-mail address, photograph, social security number or tax identification number, driver’s license number
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
10 Jul 23
Regulation FD Disclosure
4:06pm
Communication Disturbance 0.003 Social Relating 0.008 Observed values through March 1, 2020 10 | © 2023 Soleno Therapeutics
C601 Key Hormonal
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
, the Social Security Number) of the Registered Purchaser listed in response to Item 1 above:
American Stock Transfer & Trust Company, LLC Account
8-K
EX-1.1
2quxedn4jih481dw
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-99.1
pae3z7bho0fhlis r0fl
5 Feb 21
Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome
8:01am
8-K
EX-10.1
t9agf4xnl
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
8-K
EX-1.1
xpspm8yxltx fu
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
8-K
EX-10.1
cpg3q37b245r
19 Dec 18
Soleno Therapeutics Announces $16.5 Million Private Placement
4:02pm
424B3
3hzozls069gc6 2ki
24 Jul 17
Prospectus supplement
12:00am
424B3
06he4kcpr 5yvtk
14 Oct 15
Prospectus supplement
12:00am
424B3
805snp 1155v
14 Oct 15
Prospectus supplement
12:00am
S-1/A
EX-10.5
2zvlfi
1 Jul 14
IPO registration (amended)
12:00am
- Prev
- 1
- Next